Silicone adhesive multilayer foam dressings as adjuvant prophylactic therapy to prevent hospital-acquired pressure ulcers: a pragmatic noncommercial multicentre randomized open-label parallel-group medical device trial.
Dimitri BeeckmanAnika FourieC RaepsaetN Van DammeB ManderlierD De MeyerH BeeleS SmetL DemarréR VossaertA de GraafL VerhaegheN VandergheynstB HendrickxV HanssensH KeymeulenK VanderweeJ Van De WoestijneS VerhaegheA Van HeckeI SavoyeJ HarrisonF VrijensF HulstaertPublished in: The British journal of dermatology (2020)
Silicone foam dressings reduce the incidence of PUs of category 2 or worse in hospitalized at-risk patients when used in addition to standard of care. The results show a decrease for the sacrum, but no statistical difference for the heel and trochanter areas.
Keyphrases
- open label
- study protocol
- phase iii
- phase ii
- healthcare
- clinical trial
- end stage renal disease
- double blind
- ejection fraction
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- palliative care
- early stage
- randomized controlled trial
- risk factors
- placebo controlled
- squamous cell carcinoma
- chronic pain
- pain management
- mesenchymal stem cells